Sanofi Adds mRNA Specialist Tidal To Acquisition Spree

Focus Again On Cancer and Immunology

 
• By Andrew McConaghie
Sanofi building
Sanofi has made a string of acquisitions in the last 18 months, acquiring early and mid-stage companies and assets.

More from Business

More from Scrip